Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Operations (2020 - 2025)

Maravai Lifesciences Holdings has reported Cash from Operations over the past 6 years, most recently at 22768000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 22768000.0 for Q4 2025, down 55.54% from a year ago — trailing twelve months through Dec 2025 was 57573000.0 (down 871.24% YoY), and the annual figure for FY2025 was 57573000.0, down 871.24%.
  • Cash from Operations for Q4 2025 was 22768000.0 at Maravai Lifesciences Holdings, down from 15150000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for MRVI hit a ceiling of 165939000.0 in Q2 2021 and a floor of 22768000.0 in Q4 2025.
  • Median Cash from Operations over the past 5 years was 18314000.0 (2023), compared with a mean of 49033150.0.
  • Biggest five-year swings in Cash from Operations: skyrocketed 1328.66% in 2021 and later tumbled 287.91% in 2024.
  • Maravai Lifesciences Holdings' Cash from Operations stood at 58743000.0 in 2021, then skyrocketed by 69.1% to 99335000.0 in 2022, then crashed by 92.16% to 7790000.0 in 2023, then tumbled by 287.91% to 14638000.0 in 2024, then crashed by 55.54% to 22768000.0 in 2025.
  • The last three reported values for Cash from Operations were 22768000.0 (Q4 2025), 15150000.0 (Q3 2025), and 10265000.0 (Q2 2025) per Business Quant data.